Join the Cotellic group to help and get support from people like you.
Cotellic News
FDA Approves Oral MEK Inhibitor Cobimetinib for Histiocytic Neoplasms, Research Led by Memorial Sloan Kettering Cancer Center
1-Nov-2022 – Memorial Sloan Kettering Cancer Center (MSK) announced today that the U.S. Food and Drug Administration (FDA) has approved the oral MEK inhibitor drug cobimetinib (Cotellic®) for the t...
FDA Approves Cotellic (cobimetinib) for the Combination Treatment of Advanced Melanoma
November 10, 2015 – The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts...
Ask a question
To post your own question to this support group, sign in or create an account.